FDA continues to re-issue EUA, first issued under Trump, which shields liability and allows use without long-term studies of effectiveness. Scroll down this UR

FDA continues to re-issue EUA, first issued under Trump, which shields liability and allows use without long-term studies of effectiveness. Scroll down this URL and read some of the EUAs. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization https://www.fda.gov/emergency-preparedness-and-response/mcm-... "On October 19, 2022, having concluded that revising this EUA is appropriate to protect the public health or safety under section 564(g)(2) of the Act, FDA is reissuing the September 12, 2022 letter of authorization in its entirety to authorize the use of Novavax COVID‑19 Vaccine"